Potential biomarkers for differentiation of benign prostatic hyperplasia and prostate cancer

References

• Jemal A, Siegel R, Ward E et al. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71–96.
   Google Scholar
• Matthew BG, Alan WP et al. Prostate cancer tumor markers. In: Kavoussi LR, Novick AC, Partin AW, Peters CA eds Campbell-Walsh Urology. 9th edn. Philiadephia: Saunders, 2007: Ch 93, 2896–910.
   Google Scholar
• Margreiter M, Stangelberger A, Valimberti E, Herwig R, Djavan B. Biomarkers for early prostate cancer detection. Minerva Urol Nefrol 2008; 60: 51–60.
   Google Scholar
• Bensalah K, Lotan Y, Karam JA, Shariat SF. New circulating biomarkers for prostate cancer. Prostate Cancer Prostatic Dis 2008; 11: 112–20.
   Google Scholar
• Nogueira L, Corradi R, Eastham J. Prostatic specific antigen for prostate cancer detection. Int Braz J Urol 2009; 35: 521–31.
   Google Scholar
• Berbec H, Paszkowska A, Siwek B, Gradziel K Gybulski M. Total serum sialic acid concentration as a supporting marker of malignancy in ovarian neoplasia. Eur J Gyneacol Oncol 1999; 20: 389–92.
   Google Scholar
• Cherry J, Mordente J, Chapman J et al. Analysis of cathepsin D forms and their clinical implications in human prostate cancer. J Urol 1998; 160: 2223–8.
   Google Scholar
• Vashi A, Wojno K, Henricks W. Determination of the ‘reflex range’ and appropriate cutpoints for percent free-PSA in 413 men referred for prostatic evaluation using the AxSYM system. Urology 1997; 49: 19–27.
   Google Scholar
• Kuriyama K, Wang M, Papsidero L et al. Quantification of prostate specific antigen in serum by a sensitive enzyme immunoassay. Cancer Res 1980; 40: 4658–62.
   Google Scholar
• Plucinsky M, Riley W, Prorok K, Ahladeff J. Total and lipidassociated sialic acid levels in cancer patients with different primary sites and different degrees of metastatic involvements. Cancer 1986; 58: 2680–5.
   Google Scholar
• Kuhn SH, de Kock MA. A preliminary study of elevated alkaline phosphatase and cathepsin in bronchial aspirates of patients with lung cancer and bronchitis. Chest 1975; 68: 326–30.
   Google Scholar
• Babaian RJ, Miyashita H, Evans RB, Ramirez EI. The distribution of prostate specific antigen in men without clinical or pathological evidence of prostate cancer: relationship to gland volume and age. J Urol. 1992; 147 (3 Pt 2): 837–40.
   Google Scholar
• Ellis W, Etzioni R, Vessella R, Chengcheng H, Goodman G. Serial prostate specific antigen, free-to-total prostate specific antigen ratio and complexed prostate specific antigen for the diagnosis of prostate cancer. J Urol 2001; 166: 93–9.
   Google Scholar
• Martinez L , Tabernero A, Contreras T et al. Determination of the percentage of free prostate-specific antigen helps to avoid unnecessary biopsies in men with normal rectal examinations and total prostate-specific antigen of 4–10 ng/mL. Eur Urol 2000; 37: 289–96.
   Google Scholar
• Espana F, Royu M, Enguidanos M et al. Free and complexed prostate specific antigen in the differentiation of benign prostatic hyperplasia and prostate cancer: studies in serum and plasma samples. J Urol 1998; 160: 2081–8.
   Google Scholar
• Basso D, Fogar P, Piva M et al. Total PSA, free PSA/total PSA ratio and molecular PSA detection in prostate cancer: Which is clinically effective and when? Urology 2000; 55: 710–5.
   Google Scholar
• Hara N, Kitamura Y, Saito T, Komatsubara S. Total and free prostate-specific antigen indexes in prostate cancer screening: value and limitation for Japanese populations. Asian J Androl 2006; 8: 429–34.
   Google Scholar
• Mungan AG, Erol B, Akduman B et al. Values for free/total prostate-specific antigen ratio as a function of age: necessity of reference validation in a Turkish population. Clin Chem Lab Med 2007; 45: 912–6.
   Google Scholar
• Masters J, Keegan P, Hildreth A, Greene D. Free/total serum prostate-specific antigen ratio: how helpful is it in detecting prostate cancer? Br J Urol 1998; 81: 419–23.
   Google Scholar
• Lee R, Localio AR, Armstrong K, Malkowicz SB, Schwartz JS. A meta–analysis of the performance characteristics of the free prostate-specific antigen test. Urology 2006; 67: 762–8.
   Google Scholar
• de la Taille A, Houlgatte A, Houdelette P, Goluboff ET, Berlizot P, Ricordel I. Influence of free-to-total prostate specific antigen variability on the early diagnosis of prostate cancer: a comparative study of three immunoassays. Br J Urol 1998; 82: 389–92.
   Google Scholar
• Erbil K, Sabri E, Zincke H, Jones JD. Significance of serum protein and lipid-bound sialic acid as a marker for gastrointestinal malignancies. Cancer 1986; 57: 1389–94.
   Google Scholar
• Hobarth K, Hofbauer J, Fang-Kircher S. Plasma sialic acid in patients with prostate cancer. Br J Urol 1993; 72: 621–4.
   Google Scholar
• Harvey H, Lipton A, White D, Davidson E. Glyco-proteins and human cancer: II Correlations between circulating level and disease status. Cancer 1981; 47: 324–7.
   Google Scholar
• Romppanen J, Haapalainen T, Punnonen K, Penttila I. Serum sialic acid and prostate-specific antigen in differential diagnosis of benign prostate hyperplasia and prostate cancer. Anticancer Res 2002; 22: 415–20.
   Google Scholar
• Nomura T, Katunuma N. Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells. J Med Invest 2005; 52: 1–9.
   Google Scholar
• Miyake H, Hara I, Eto H. Prediction of the extent of prostate cancer by the combined use of systematic biopsy and serum level of cathepsin D. Int J Urol 2003; 10: 196–200.
   Google Scholar
• Mordente J, Choudhury M, Tazaki H, Mallouh C, Konno S. Hydrolysis of androgen receptor by cathepsin D: its biological significance in human prostate cancer. Br J Urol 1998; 82: 431–5.
   Google Scholar
• Gómez Díaz ME, Ruibal-Morell A, Abascal García R. Proteases and prostatic disease: cytosolic cathepsin D (in Spanish). Arch Esp Urol 2001; 54: 101–7.
   Google Scholar
• Hara I, Miyake H, Yamanaka K, Hara S, Kamidono S. Serum cathepsin D and its density in men with prostate cancer as new predictors of disease progression. Oncol Rep 2002; 9 (6): 1379–83.
   Google Scholar